Published in Br J Haematol on June 21, 2013
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? Dis Model Mech (2014) 0.98
Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol (2014) 0.97
'Acute myeloid leukemia: a comprehensive review and 2016 update'. Blood Cancer J (2016) 0.86
The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse. Leukemia (2015) 0.81
Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia. Cancer Biol Ther (2015) 0.80
Is targeted therapy feasible in acute myelogenous leukemia? Curr Hematol Malig Rep (2014) 0.79
Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood Cancer J (2016) 0.75
Extracorporeal Life Support in Patients with Hematologic Malignancies: A Single Center Experience. Korean J Thorac Cardiovasc Surg (2016) 0.75
Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies. Blood Transfus (2014) 0.75
Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia. Oncotarget (2016) 0.75
Elderly acute myeloid leukemia: assessing risk. Curr Hematol Malig Rep (2015) 0.75
A three-gene expression-based risk score can refine the European LeukemiaNet AML classification. J Hematol Oncol (2016) 0.75
Chemotherapy-induced hypomethylation of N-myc downstream-regulated gene 4 in the bone marrow of patients with acute myeloid leukemia. Oncol Lett (2017) 0.75
Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med (2009) 7.24
Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18
Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA (2008) 6.07
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med (2004) 5.67
Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ (2010) 5.60
Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer (2004) 4.16
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol (2007) 3.32
Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut (2011) 3.07
Modeling smoking history: a comparison of different approaches. Am J Epidemiol (2002) 2.92
Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol (2013) 2.84
Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ (2008) 2.63
Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet (2003) 2.27
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax (2013) 2.19
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer (2007) 2.16
Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol (2007) 2.13
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol (2011) 2.11
Screening and cervical cancer cure: population based cohort study. BMJ (2012) 1.99
Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst (2009) 1.92
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood (2010) 1.89
Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol (2008) 1.85
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood (2008) 1.78
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
Geographical variation in life expectancy at birth in England and Wales is largely explained by deprivation. J Epidemiol Community Health (2005) 1.66
Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med (2008) 1.65
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy. Haematologica (2006) 1.63
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood (2008) 1.61
The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica (2006) 1.59
Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer (2012) 1.54
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase. Leuk Lymphoma (2006) 1.52
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica (2009) 1.50
Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol (2012) 1.49
A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res (2004) 1.47
Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol (2012) 1.46
A general framework for parametric survival analysis. Stat Med (2014) 1.43
Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol (2009) 1.43
Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib. Leuk Lymphoma (2014) 1.43
CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res (2008) 1.42
Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? Leuk Lymphoma (2009) 1.41
The impact of plasma preparations and their storage time on short-term posttransfusion mortality: a population-based study using the Scandinavian Donation and Transfusion database. J Trauma Acute Care Surg (2012) 1.41
Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med (2007) 1.40
Effect of NHS walk-in centre on local primary healthcare services: before and after observational study. BMJ (2003) 1.40
Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden. Int J Cancer (2012) 1.39
Cancer risk among patients with myotonic muscular dystrophy. JAMA (2011) 1.38
Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology (2008) 1.36
Evidence-based sample size calculations based upon updated meta-analysis. Stat Med (2007) 1.35
Choosing the relative survival method for cancer survival estimation. Eur J Cancer (2011) 1.34
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol (2003) 1.33
The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology (2009) 1.29
Survival from malignant digestive endocrine tumors in England and Wales: a population-based study. Gastroenterology (2007) 1.27
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry. Blood (2013) 1.27
FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol (2009) 1.27
Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. Eur J Cancer (2011) 1.27
Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica (2010) 1.25
Estimating net survival in population-based cancer studies. Int J Cancer (2013) 1.24
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst (2010) 1.24
Meta-analysis of heterogeneously reported trials assessing change from baseline. Stat Med (2005) 1.23
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden. Haematologica (2009) 1.21
Cancer incidence, survival and mortality: explaining the concepts. Int J Cancer (2014) 1.21
The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp Cell Res (2002) 1.21
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica (2009) 1.19
Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res (2003) 1.18
Highly increased familial risks for specific lymphoma subtypes. Br J Haematol (2009) 1.16
Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev (2011) 1.12
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer (2009) 1.12
Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions. BMC Med Res Methodol (2013) 1.11
Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open (2013) 1.10
Trends in cancer survival in Spearhead Primary Care Trusts in England, 1998-2004. Health Stat Q (2009) 1.10
Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. Oncoimmunology (2012) 1.10
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood (2010) 1.09
How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006. Eur J Cancer (2011) 1.09
Bayesian implementation of a genetic model-free approach to the meta-analysis of genetic association studies. Stat Med (2005) 1.07
Comments on 'trying to be precise about vagueness' by Stephen Senn, Statistics in Medicine 2007; 26:1417-1430. Stat Med (2008) 1.07
Socio-economic disparities in access to treatment and their impact on colorectal cancer survival. Int J Epidemiol (2010) 1.06
Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study. BMC Med Res Methodol (2011) 1.06
The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Cancer Res (2007) 1.06
Cancer incidence in South Asian migrants to England, 1986-2004: unraveling ethnic from socioeconomic differentials. Int J Cancer (2012) 1.06
Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data. BMJ (2011) 1.06
Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res (2004) 1.05
Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005. Am J Hematol (2012) 1.05
Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis. Health Econ (2007) 1.04
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders. Haematologica (2004) 1.04
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica (2009) 1.03
Estimating the loss in expectation of life due to cancer using flexible parametric survival models. Stat Med (2013) 1.03
Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation. Mol Cell Biol (2006) 1.01
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues. Clin Cancer Res (2005) 1.01
Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present. J Clin Epidemiol (2004) 1.01
Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci U S A (2008) 1.00
Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas. Genes Chromosomes Cancer (2002) 1.00
Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. FASEB J (2009) 1.00